Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study

The Breast Journal ◽

10.1111/tbj.13197 ◽

2019 ◽

Vol 25 (2) ◽

pp. 237-242 ◽

Author(s):

Gabriella Mariani ◽

Giulia Galli ◽

Stefano Cavalieri ◽

Pinuccia Valagussa ◽

Giulia Valeria Bianchi ◽

...

Keyword(s):

Breast Cancer ◽

Operable Breast Cancer ◽

Single Institution

Download Full-text

Abstract OT1-01-05: Endocrine treatment alone as primary treatment for elderly patients with estrogen receptor positive good prognosis operable breast cancer: A single arm phase II, single institution study

10.1158/1538-7445.sabcs18-ot1-01-05 ◽

2019 ◽

Author(s):

R Aft ◽

M Cherian ◽

A Frith ◽

R Suresh ◽

K Glover-Collins ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Elderly Patients ◽

Phase Ii ◽

Primary Treatment ◽

Good Prognosis ◽

Operable Breast Cancer ◽

Endocrine Treatment ◽

Single Institution ◽

Estrogen Receptor Positive

Download Full-text

Long term results of ASTER study, a single Institution phase II trial of sequential chemotherapy (CT) for operable breast cancer (BC)

Annals of Oncology ◽

10.1093/annonc/mdx424.033 ◽

2017 ◽

Vol 28 ◽

pp. vi34 ◽

Author(s):

G. Mariani ◽

G. Galli ◽

S. Cavalieri ◽

P. Valagussa ◽

G. Bianchi ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Operable Breast Cancer ◽

Long Term Results ◽

Single Institution ◽

Sequential Chemotherapy

Download Full-text

Prognosis of operable breast cancer in young patients treated in a single institution: independent pejorative value of postive Estrogen Receptor

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80305-8 ◽

2006 ◽

Vol 4 (2) ◽

pp. 130 ◽

Author(s):

A. Durieux ◽

Debled ◽

V. Brouste ◽

G. MacGrogan ◽

E. Bussières ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Young Patients ◽

Operable Breast Cancer ◽

Single Institution

Download Full-text

Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution

10.1016/j.breast.2017.08.007 ◽

2017 ◽

Vol 36 ◽

pp. 20-24

Author(s):

Yang Yang ◽

Yingjian He ◽

Zhaoqing Fan ◽

Tao Ouyang

Keyword(s):

Breast Cancer ◽

Sentinel Lymph Node ◽

Sentinel Lymph Node Biopsy ◽

Lymph Node Biopsy ◽

Operable Breast Cancer ◽

Chinese Patients ◽

Single Institution ◽

Download Full-text

Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution

Breast Cancer Targets and Therapy ◽

10.2147/bctt.s179750 ◽

2018 ◽

Vol Volume 11 ◽

pp. 29-42 ◽

Author(s):

Silvia Antolín ◽

Benigno Acea ◽

Luis Albaina ◽

Ángel Concha ◽

Paz Santiago ◽

...

Keyword(s):

Breast Cancer ◽

Operable Breast Cancer ◽

Single Institution ◽

Her2 Positive ◽

Efficacy Data ◽

Primary Systemic Therapy ◽

Long Term Follow Up ◽

Chemotherapy Efficacy

Download Full-text

Abstract P1-18-28: Myocet or carboplatin as part of chemotherapy in HER2-positive operable breast cancer treated with trastuzumab and pertuzumab in the neoadjuvant setting: Efficacy data and cardiotoxicity in 60 patients diagnosed from 2016-2019 at a single institution

10.1158/1538-7445.sabcs19-p1-18-28 ◽

2020 ◽

Author(s):

Silvia Antolin ◽

Cristina Reboredo ◽

Rocío Lesta ◽

Aurea Molina ◽

Joaquin Mosquera ◽

...

Keyword(s):

Breast Cancer ◽

Operable Breast Cancer ◽

Single Institution ◽

Her2 Positive ◽

Download Full-text

Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction

Annals of Surgical Oncology ◽

10.1245/s10434-016-5407-9 ◽

2016 ◽

Vol 23 (10) ◽

pp. 3190-3198 ◽

Author(s):

Stacey A. Carter ◽

Genevieve R. Lyons ◽

Henry M. Kuerer ◽

Roland L. Bassett ◽

Scott Oates ◽

...

Keyword(s):

Breast Cancer ◽

Breast Conservation ◽

Operable Breast Cancer ◽

Oncologic Outcomes ◽

Single Institution

Download Full-text

Abstract P1-15-17: Liposomal-encapsulated doxorubicin (Myocet)as part of primary systemic therapy in HER2-positive operable breast cancer: Efficacy data, cardiotoxicity and long-term follow-up in 81 patients diagnosed from 2005-2016 at a single institution

10.1158/1538-7445.sabcs18-p1-15-17 ◽

2019 ◽

Author(s):

S Antolin ◽

L Calvo ◽

J Prato ◽

A Molina ◽

C Reboredo ◽

...

Keyword(s):

Breast Cancer ◽

Systemic Therapy ◽

Operable Breast Cancer ◽

Single Institution ◽

Her2 Positive ◽

Efficacy Data ◽

Primary Systemic Therapy ◽

Long Term Follow Up

Download Full-text

Anthracycline and concurrent radiotherapy as adjuvant treatment of operable breast cancer: a retrospective cohort study in a single institution

BMC Research Notes ◽

10.1186/1756-0500-3-247 ◽

2010 ◽

Vol 3 (1) ◽

Author(s):

Nabil Ismaili ◽

Sanaa Elmajjaoui ◽

Issam Lalya ◽

Lamia Boulaamane ◽

Rhizlane Belbaraka ◽

...

Keyword(s):

Breast Cancer ◽

Cohort Study ◽

Adjuvant Treatment ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Operable Breast Cancer ◽

Single Institution ◽

Concurrent Radiotherapy

Download Full-text

Value of detection of bone marrow (BM) micrometastases by quantitative real-time RT-PCR in primary operable breast cancer(BC)

European Journal of Cancer ◽

10.1016/s0959-8049(02)80348-3 ◽

2002 ◽

Vol 38 (11) ◽

pp. S108-S109

Author(s):

M Saad Ismail

Keyword(s):

Breast Cancer ◽

Bone Marrow ◽

Real Time ◽

Operable Breast Cancer ◽

Rt Pcr ◽

Primary Operable Breast Cancer

Download Full-text